14 days ago
NBIX
AnalystsBrian AbrahamsBrian Abrahams's Stock Forecasts
AnalystsBrian Abrahams
Analyst Ranking
Top 13%
#669 out of 5294 analysts
Average Return
+4.54%
Win Rate
46%142 out of 312
Risk vs Reward
Poor
Good
Brian Abrahams's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +558.80% | $2.67 | $17.59 | 2022-05-12 - 2023-05-11 | Buy |
Pliant Therapeutics IncPLRX | +382.01% | $4.67 | $22.51 | 2022-05-10 - 2023-05-09 | Buy |
Cidara Therapeutics IncCDTX | +372.63% | $46.84 | $221.38 | 2025-06-24 - 2026-01-06 | Buy |
Contineum Therapeutics IncCTNM | +260.66% | $3.94 | $14.21 | 2025-05-15 - 2026-05-14 | Buy |
Ambrx Biopharma IncAMAM | +233.33% | $8.40 | $28.00 | 2023-10-23 - 2024-03-06 | Buy |
Brian Abrahams Analyst Color
Get additional color on Brian Abrahams's coverage of popular stocks
4 months ago
NBIX
10 months ago
GILD
2 years ago
APLT
2 years ago
DFTX
Brian Abrahams's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Apogee Therapeutics IncAPGE | 5 | Hold | $97.00 | +8.38% | Maintains | 4 days ago |
Neurocrine Biosciences IncNBIX | 26 | Buy | $183.00 | +12.47% | Maintains | 14 days ago |
Biogen IncBIIB | 42 | Buy | $227.00 | +13.52% | Maintains | 16 days ago |
Regeneron Pharmaceuticals IncREGN | 38 | Hold | $707.00 | +15.62% | Maintains | 25 days ago |
Xenon Pharmaceuticals IncXENE | 21 | Buy | $82.00 | +57.12% | Maintains | a month ago |
Ptc Therapeutics IncPTCT | 21 | Hold | $82.00 | +9.76% | Maintains | a month ago |
Gilead Sciences IncGILD | 34 | Hold | $122.00 | -3.07% | Maintains | a month ago |
Vertex Pharmaceuticals IncVRTX | 58 | Buy | $543.00 | +22.01% | Maintains | a month ago |
Damora Therapeutics IncDMRA | 1 | Buy | $40.00 | +87.27% | Initiates Coverage On | 2 months ago |
Evommune IncEVMN | 1 | Buy | $48.00 | +132.00% | Reiterates | 2 months ago |
Pharvaris NvPHVS | 2 | Buy | $51.00 | +58.39% | Maintains | 2 months ago |
Moonlake ImmunotherapeuticsMLTX | 5 | Hold | $13.00 | -26.76% | Maintains | 3 months ago |
Aardvark Therapeutics IncAARD | 6 | Hold | $6.00 | +64.84% | Downgrades | 3 months ago |
Acadia Pharmaceuticals IncACAD | 5 | Buy | $30.00 | +40.25% | Maintains | 4 months ago |
Lakefront Biotherapeutics NvLKFT | 13 | Hold | $33.00 | +14.03% | Maintains | 4 months ago |
Prothena Corp Public Ltd CoPRTA | 13 | Hold | $12.00 | +45.28% | Maintains | 4 months ago |
Incyte CorpINCY | 24 | Hold | $92.00 | -14.68% | Maintains | 4 months ago |
Biocryst Pharmaceuticals IncBCRX | 16 | Buy | $13.00 | +52.94% | Maintains | 4 months ago |
Nurix Therapeutics IncNRIX | 1 | Buy | $30.00 | +76.68% | Maintains | 4 months ago |
Gh Research PLCGHRS | 2 | Buy | $40.00 | +93.61% | Maintains | 5 months ago |
Definium Therapeutics IncDFTX | 11 | Buy | $36.00 | +49.32% | Maintains | 5 months ago |
Kymera Therapeutics IncKYMR | 2 | Buy | $103.00 | +24.16% | Maintains | 6 months ago |
Sionna Therapeutics IncSION | 2 | Sell | $24.00 | -33.43% | Downgrades | 6 months ago |
Neumora Therapeutics IncNMRA | 7 | Buy | $7.00 | +293.26% | Upgrades | 6 months ago |
Contineum Therapeutics IncCTNM | 6 | Buy | $22.00 | +85.50% | Maintains | 7 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 8 | Buy | $53.00 | +581.23% | Maintains | 7 months ago |
Atyr Pharma IncATYR | 2 | Hold | $1.00 | +110.53% | Maintains | 7 months ago |
Pliant Therapeutics IncPLRX | 14 | Hold | $2.00 | +75.44% | Maintains | 7 months ago |
Cidara Therapeutics IncCDTX | 2 | Buy | $145.00 | -34.50% | Maintains | 7 months ago |
Karyopharm Therapeutics IncKPTI | 12 | Buy | $19.00 | +111.11% | Maintains | 7 months ago |
89bio IncETNB | 14 | Hold | $11.00 | -25.88% | Maintains | 10 months ago |
Sarepta Therapeutics IncSRPT | 31 | Hold | $23.00 | +53.33% | Maintains | a year ago |
Applied Therapeutics IncAPLT | 6 | Hold | $1.50 | N/A | Reiterates | a year ago |
Legend Biotech CorpLEGN | 1 | Buy | $84.00 | N/A | Reiterates | a year ago |
Axsome Therapeutics IncAXSM | 2 | Buy | $143.00 | N/A | Maintains | a year ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $40.00 | N/A | Reiterates | a year ago |
Intra Cellular Therapies IncITCI | 18 | Hold | $132.00 | N/A | Downgrades | a year ago |
Igm Biosciences IncIGMS | 15 | Hold | $1.50 | N/A | Downgrades | a year ago |
Hookipa Pharma IncHOOK | 11 | Hold | $2.00 | N/A | Downgrades | a year ago |
Sage Therapeutics IncSAGE | 19 | Hold | $4.00 | N/A | Upgrades | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 8 | Hold | $1.00 | N/A | Maintains | 2 years ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $32.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 7 | Buy | $225.00 | N/A | Maintains | 3 years ago |
Enanta Pharmaceuticals IncENTA | 14 | Hold | $15.00 | N/A | Maintains | 3 years ago |
Intercept Pharmaceuticals IncICPT | 11 | Hold | $19.00 | N/A | Maintains | 3 years ago |
Ataibeckley IncATAI | 3 | Hold | $9.00 | N/A | Maintains | 4 years ago |
Merus NvMRUS | 3 | Hold | $33.00 | N/A | Maintains | 5 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $34.00 | N/A | Downgrades | 5 years ago |
Metacrine IncMTCR | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 6 years ago |
Neubase Therapeutics IncNBSE | 1 | Buy | $320.00 | N/A | Initiates Coverage On | 6 years ago |
Celgene CorpCELG | 2 | Buy | $118.00 | N/A | Downgrades | 8 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 9 years ago |
Immune Design CorpIMDZ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 9 years ago |
Avexis IncAVXS | 1 | Hold | $92.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.